# Saxenda

NDC: 0169-2800
Generic name: liraglutide
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20141231

FDA application: NDA206321

## Active ingredients

- LIRAGLUTIDE: 6 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-2800"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-2800
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143